Cite
HARVARD Citation
Valery, S. et al. (n.d.). 81P Efficacy of weekly paclitaxel-bevacizumab combination in advanced non squamous non-small cell lung cancer (NSCLC) progressing after immune checkpoint inhibitors - AVATAX, a retrospective multicentric study: Preliminary data. Annals of oncology. p. . [Online].